CurosurfCompany: Dey Laboratories
Approval Status: Approved October 1998
Treatment for: Pediatric Respiratory Distress Syndrome
Areas: Pediatrics; Respiratory
Curosurf is used as a treatment for respiratory distress syndrome in premature infants.
Curosurf Drug Information
The Curosurf drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.